Poland

Abstract

In our report, we analyse to which extent the pharmaceutical sector in Poland is treated differently than other sectors of economy in terms of competition law. We consider the general legislative framework and specific provisions of pharmaceutical law concerning competition law aspects, as well as the enforcement of competition law in the pharmaceutical sector. We also reflect upon the interplay between competition law and intellectual property, and we include some budgetary considerations. At the end of our report, we briefly present our conclusions.